Alcon, the eye care division of Novartis, acquired fluid-based intraocular lens maker PowerVision Inc. for $285 million.
Artificial intelligence generated plenty of chatter amongst the pharma marketing intelligentsia in 2018. Will 2019 be the year when the industry fully embraces it as more than just a tactic?
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
Med Ad News spoke with Gene Fitzpatrick, senior VP of engagement strategy for Ogilvy CommonHealth Worldwide, about the future of augmented and virtual reality in healthcare marketing.
Augmented reality (AR) and virtual reality (VR) have experienced incredible growth since 2013, when the first Oculus Rift VR headset hit the market and provided a whole new sense of what was possible.
As private practices close and the number of doctors joining rep-restricted hospital-based and integrated delivery networks of healthcare increases, pharma needs to look at the advantages of mobile marketing to “detail” these hospital-based professionals.
The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc.
A new study shows first-time proof that AI can detect the severity of diabetic macular edema, which is a leading cause of blindness.
Fitbit launched the company’s cheapest smartwatch to defend its position as the second-largest seller of smartwatches after Apple.
A new wireless system for monitoring the vital signs of the most fragile newborns – those born prematurely or with debilitating diseases – could make it easier for parents to have skin to skin contact with their babies, a preliminary study suggests.
HCB Health, one of the leading independent healthcare communications agencies in the United States, announced the creation of three internal business units to best serve an increasingly diverse set of clients and to help manage the firm’s rapid growth.
Fitbit Inc. forecast first-quarter 2019 revenue below analysts’ estimates as management expects the wearable device maker’s average selling price to drop, sending the company’s shares down 11 percent.
Researchers are having a hard time getting their hands on specimens for their work on new treatments, diagnostics, and cures.
Ireland’s Teckro, which makes software that allows physicians to take part in drug development trials from mobile devices, has won $25 million in financial backing from investors as the company hatches longer-term plans for a stock market listing.
After the U.S. Food and Drug Administration took a hard line on the use of real-world evidence in clinical trials, industry leaders are beginning to back the idea, but with some minor changes.